A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)-Study protocol.
Suzanne PenfoldAyola Akim AdegnikaDanny AsogunOlufemi AyodejiBenedict N AzuoguWilliam A FischerRobert F GarryDonald Samuel GrantChristian HappiMagassouba N'FalyAdebola Tolulope OlayinkaRobert SamuelsJefferson SibleyDavid A WohlManfred AccrombessiIfedayo AdetifaGiuditta AnnibaldisAnton CamachoChioma Dan-NwaforAkpénè Ruth Esperencia DehaJean DeMarcoSophie DuraffourAugustine GobaRebecca F GraisStephan GüntherÉnagnon Junior Juvénal Prince HonvouChikwe IhekweazuChristine JacobsenLansana KannehMambu MomohAminata NdiayeRobert NsaibirniSylvanus OkogbeninChinwe OchuEphraim OgbainiÉnagnon Parsifal Marie Alexandre LogboJohn Demby SandiJohn S SchieffelinThomas VerstraetenNathalie J VielleAnges YadouletonEmmanuel Koffi Yovonull nullPublished in: PloS one (2023)
Data on LASV infection and LF disease incidence in West Africa from this research programme will determine the feasibility of future Phase IIb or III clinical trials for LF vaccine candidates.